about
Association of Interferon Gamma +874T/A Polymorphism and Leukemia Risk: A Meta-AnalysisTargeting caspases in cancer therapeuticsShedding light on melanocyte pathobiology in vivoThe Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionMechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapyHigh-content pSTAT3/1 imaging assays to screen for selective inhibitors of STAT3 pathway activation in head and neck cancer cell lines.Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.Neighbours of cancer-related proteins have key influence on pathogenesis and could increase the drug target space for anticancer therapiesSecretion of interferon gamma from human immune cells is altered by exposure to tributyltin and dibutyltin.PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression.A novel mechanism of skin tumor promotion involving interferon-gamma (IFNγ)/signal transducer and activator of transcription-1 (Stat1) signaling.Methylation patterns of the IFN-γ gene in cervical cancer tissues.PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice.Type II interferon promotes differentiation of myeloid-biased hematopoietic stem cells.Interferon-stimulated genes: a complex web of host defenses.ADAM17 silencing in mouse colon carcinoma cells: the effect on tumoricidal cytokines and angiogenesis.Adenovirus-mediated delivery of interferon-γ gene inhibits the growth of nasopharyngeal carcinomaInterleukin-27 signaling promotes immunity against endogenously arising murine tumors.Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells.Long Non-Coding RNA BST2/BISPR is Induced by IFN and Regulates the Expression of the Antiviral Factor Tetherin.Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer.Gene expression profiling of the leading edge of cutaneous squamous cell carcinoma: IL-24-driven MMP-7.In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice.Epigenetic regulation of inflammatory cytokines and associated genes in human malignanciesIFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.Interferon-γ Promotes Inflammation and Development of T-Cell Lymphoma in HTLV-1 bZIP Factor Transgenic Mice.New PARP targets for cancer therapyInterferon-γ polymorphism and hepatocellular carcinoma susceptibility: a meta analysis.Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.Attenuated Toxoplasma gondii Stimulates Immunity to Pancreatic Cancer by Manipulation of Myeloid Cell Populations.Inhibition of NF-κB in Tumor Cells Exacerbates Immune Cell Activation Following Photodynamic Therapy.Disabling of the erbB Pathway Followed by IFN-γ Modifies Phenotype and Enhances Genotoxic Eradication of Breast Tumors.LBH589 enhances T cell activation in vivo and accelerates graft-versus-host disease in mice.Conservation of immune gene signatures in solid tumors and prognostic implications.Attenuated mutant strain of Salmonella Typhimurium lacking the ZnuABC transporter contrasts tumor growth promoting anti-cancer immune response.Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ.Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide.T Cell Intrinsic USP15 Deficiency Promotes Excessive IFN-γ Production and an Immunosuppressive Tumor Microenvironment in MCA-Induced FibrosarcomaRapid Detection of Neutrophil Oxidative Burst Capacity is Predictive of Whole Blood Cytokine ResponsesElevated and cross-responsive CD1a-reactive T cells in bee and wasp venom allergic individuals.
P2860
Q26750761-3FCC9623-DC42-4E75-9AB2-C055E37EE110Q26821986-61A2DD17-C359-4D83-9517-A4734C3ABA61Q26866190-CCB3AA9E-1445-44F5-96E7-F1638234C8FFQ28076760-10BB1329-9225-4D2E-9149-F3D9B41D4616Q28083766-7803B1A4-45B8-4A94-9E62-38F8FF530C8FQ30408290-24C32BC0-60EB-4A6B-A300-1F30793D833DQ33674627-37276462-9C5E-445F-AEEA-427C79E3ACB5Q33767131-C71219F3-E355-4605-B5F7-664D5A7E35B2Q33784818-C752BE6E-186D-4BAA-B4A5-186119F4B9C9Q33839204-14D84316-6DA9-4FD2-8704-95EEF2F8DA6DQ34071264-FEACDDEA-115F-457A-A1FB-5ABB32E71EDEQ34162497-CA6413AD-AA82-4DCE-9663-C1B7D31175DFQ34294045-BC9C8302-52F1-4E12-8048-A2DB3C90596DQ34345184-950788F0-C7AA-4104-B41E-2FA6CA5D12ACQ34405609-B4A0A8B6-4B0B-4C77-9392-7931D081B0B5Q34515863-BF8143FA-1131-4227-BEF3-8F609F33CE58Q34526425-608D7C88-7546-4E42-A5A8-02427345DD1BQ34647840-10C7AA62-231D-44C5-B24F-2E7FD6AADDE8Q34655638-E8ED1E1E-BDF4-44A5-BAEC-25D7AAE02DDEQ34885158-641DFE15-30DB-4F6A-B1D3-7FAB648F2BBFQ35040765-25DF2E4D-E75C-40D7-8113-720456953B68Q35051986-0D01D4AC-C25C-4C71-A98D-AE2F9ACEE5A5Q35174206-BAE386A4-B757-4C8D-87A3-9749A405C331Q35178132-DF298404-325F-4467-A8DB-FDC62F341525Q35677893-F74877A6-E856-4851-8C24-6C3C43F18883Q35752462-C2199A46-0BEE-4B11-8E6F-4BBBBAC5C903Q35779661-187B0085-B969-41B7-90D0-E8D85910D3A3Q35791992-CBDF60F4-3AFD-4DAC-B6D3-9953793859C1Q35861936-173969A5-0C39-4037-8A0B-02482A4762D5Q35920573-BAC28D2C-A92C-43D2-984A-6CDCFAF29E40Q36088759-FCE90B49-C0BE-48D2-8451-14A7B9BA6D11Q36113684-BC9D2774-B324-4FDA-8E04-1C7C4D448F3DQ36157978-384D137D-B3FD-4B4C-9A1F-93A8A9A07EB2Q36200301-6F09FB26-144D-4985-9B43-4329A35E27D6Q36232119-CE9B27D7-7754-48AB-8DF7-29CD2FFE65E3Q36269050-F566F075-BFF5-407B-9327-F81764AE8316Q36276014-F6D7E5E4-40EB-43AF-A41F-3261A7089F35Q36405486-5ED56CC6-4DF7-44ED-8667-EAD849245632Q36418414-C90365B0-B6AB-4D17-A911-0F337323356DQ36536816-75AE1394-0912-419B-925D-69630CB8B034
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The two faces of interferon-γ in cancer.
@ast
The two faces of interferon-γ in cancer.
@en
type
label
The two faces of interferon-γ in cancer.
@ast
The two faces of interferon-γ in cancer.
@en
prefLabel
The two faces of interferon-γ in cancer.
@ast
The two faces of interferon-γ in cancer.
@en
P2860
P1476
The two faces of interferon-γ in cancer.
@en
P2093
Glenn Merlino
M Raza Zaidi
P2860
P304
P356
10.1158/1078-0432.CCR-11-0482
P407
P577
2011-06-24T00:00:00Z